SIGHINOLFI, GIAN LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 986
EU - Europa 388
AS - Asia 108
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 983
SE - Svezia 102
IT - Italia 80
GB - Regno Unito 64
HK - Hong Kong 59
DE - Germania 46
FI - Finlandia 43
CN - Cina 26
BG - Bulgaria 11
SI - Slovenia 11
MY - Malesia 7
UA - Ucraina 7
FR - Francia 6
IN - India 4
PL - Polonia 4
VN - Vietnam 4
CA - Canada 3
CZ - Repubblica Ceca 3
IR - Iran 3
BE - Belgio 2
BY - Bielorussia 2
NL - Olanda 2
SG - Singapore 2
TR - Turchia 2
AU - Australia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
PT - Portogallo 1
RO - Romania 1
ZM - Zambia 1
Totale 1.485
Salva come PNG Salva come JPEG
Città #
Chandler 182
Fairfield 144
Ashburn 117
Nyköping 80
Hong Kong 59
Woodbridge 56
Houston 55
Helsinki 42
Seattle 41
Southend 39
Cambridge 35
Wilmington 35
Modena 22
San Diego 20
Princeton 19
Bremen 18
Ann Arbor 16
Fremont 15
Jacksonville 14
Shanghai 12
London 11
Sofia 11
New York 10
Dearborn 8
Genoa 6
Beijing 5
Milan 5
Dong Ket 4
Leawood 4
Munich 4
San Mateo 4
Brno 3
Phoenix 3
Redwood City 3
Atlanta 2
Berlin 2
Boardman 2
Borgo Tossignano 2
Brussels 2
Celico 2
Chicago 2
Edinburgh 2
Eugene 2
Falls Church 2
Hounslow 2
Kilburn 2
Minsk 2
Paris 2
Parma 2
Rome 2
Stockholm 2
Toronto 2
Tulare 2
Venice 2
Warsaw 2
Amsterdam 1
Andover 1
Ardabil 1
Augusta 1
Bangalore 1
Bari 1
Birmingham 1
Bologna 1
Breda di Piave 1
Bucharest 1
Budapest 1
Cadoneghe 1
Chiswick 1
Copenhagen 1
Dallas 1
Ferrara 1
Garbsen 1
Hanover 1
Henderson 1
Istanbul 1
Izmir 1
Jinan 1
Kish 1
Lisbon 1
Lombard 1
Los Angeles 1
Lusaka 1
Manchester 1
Mornico al Serio 1
Mumbai 1
New Orleans 1
Nicosia 1
Ottawa 1
Padova 1
Philadelphia 1
Polska 1
Reggio Emilia 1
Reggio Nell'emilia 1
Saint Louis 1
San Giorgio a Cremano 1
San Jose 1
Singapore 1
Southwark 1
Sydney 1
Washington 1
Totale 1.189
Salva come PNG Salva come JPEG
Nome #
Carcinogenic potential of metal nanoparticles in BALB/3T3 cell transformation assay. 221
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 115
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 108
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 107
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 101
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 99
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 86
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 83
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 80
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 80
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 70
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 54
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 53
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 52
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 51
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 50
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 44
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection 36
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV 21
Totale 1.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.734
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 8 8
2019/202067 8 3 1 2 9 9 14 6 7 3 5 0
2020/2021362 9 0 4 15 109 74 23 37 15 25 43 8
2021/2022265 18 12 9 5 13 12 8 13 42 12 51 70
2022/2023502 72 70 38 43 60 55 14 59 42 0 20 29
2023/2024255 9 17 25 40 56 34 28 32 4 10 0 0
Totale 1.511